Circ‐CTNNB1 drives aerobic glycolysis and osteosarcoma progression via m6A modification through interacting with RBM15

por Yang, Feng, Liu, Yangyang, Xiao, Jun, Li, Bo, Chen, Yajun, Hu, Anpei, Zeng, Jin, Liu, Zhili, Liu, Hucheng
Publicado 2022

Robot-Assisted versus Trans-Umbilical Multiport Laparoscopic Ureteral Reimplantation for Pediatric Benign Distal Ureteral Stricture: Mid-Term Results at a Single Center

por Guo, Yanhua, Cheng, Yang, Li, Dan, Mei, Hong, Jin, Huan, Chen, Guo, Hu, Anpei, Li, Qilan, Du, Xinyi, Zheng, Liduan, Tong, Qiangsong
Publicado 2022

Correction: Circ-HuR suppresses HuR expression and gastric cancer progression by inhibiting CNBP transactivation

por Yang, Feng, Hu, Anpei, Li, Dan, Wang, Jianqun, Guo, Yanhua, Liu, Yang, Li, Hongjun, Chen, Yajun, Wang, Xiaojing, Huang, Kai, Zheng, Liduan, Tong, Qiangsong
Publicado 2023

Circ-HuR suppresses HuR expression and gastric cancer progression by inhibiting CNBP transactivation

por Yang, Feng, Hu, Anpei, Li, Dan, Wang, Jianqun, Guo, Yanhua, Liu, Yang, Li, Hongjun, Chen, Yajun, Wang, Xiaojing, Huang, Kai, Zheng, Liduan, Tong, Qiangsong
Publicado 2019

Therapeutic targeting of SPIB/SPI1‐facilitated interplay of cancer cells and neutrophils inhibits aerobic glycolysis and cancer progression

por Wang, Jianqun, Wang, Xiaojing, Guo, Yanhua, Ye, Lin, Li, Dan, Hu, Anpei, Cai, Shuang, Yuan, Boling, Jin, Shikai, Zhou, Yi, Li, Qilan, Zheng, Liduan, Tong, Qiangsong
Publicado 2021

Therapeutic targeting of CNBP phase separation inhibits ribosome biogenesis and neuroblastoma progression via modulating SWI/SNF complex activity

por Hu, Anpei, Chen, Guo, Bao, Banghe, Guo, Yanhua, Li, Dan, Wang, Xiaojing, Wang, Jianqun, Li, Qilan, Zhou, Yi, Gao, Haiyang, Song, Jiyu, Du, Xinyi, Zheng, Liduan, Tong, Qiangsong
Publicado 2023

Retraction Note: HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression

por Song, Huajie, Li, Dan, Wang, Xiaojing, Fang, Erhu, Yang, Feng, Hu, Anpei, Wang, Jianqun, Guo, Yanhua, Liu, Yang, Li, Hongjun, Chen, Yajun, Huang, Kai, Zheng, Liduan, Tong, Qiangsong
Publicado 2023

Therapeutic Targeting of MZF1‐AS1/PARP1/E2F1 Axis Inhibits Proline Synthesis and Neuroblastoma Progression

por Fang, Erhu, Wang, Xiaojing, Yang, Feng, Hu, Anpei, Wang, Jianqun, Li, Dan, Song, Huajie, Hong, Mei, Guo, Yanhua, Liu, Yang, Li, Hongjun, Huang, Kai, Zheng, Liduan, Tong, Qiangsong
Publicado 2019

RETRACTED ARTICLE: HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression

por Song, Huajie, Li, Dan, Wang, Xiaojing, Fang, Erhu, Yang, Feng, Hu, Anpei, Wang, Jianqun, Guo, Yanhua, Liu, Yang, Li, Hongjun, Chen, Yajun, Huang, Kai, Zheng, Liduan, Tong, Qiangsong
Publicado 2020

Therapeutic targeting of circ‐CUX1/EWSR1/MAZ axis inhibits glycolysis and neuroblastoma progression

por Li, Huanhuan, Yang, Feng, Hu, Anpei, Wang, Xiaojing, Fang, Erhu, Chen, Yajun, Li, Dan, Song, Huajie, Wang, Jianqun, Guo, Yanhua, Liu, Yang, Li, Hongjun, Huang, Kai, Zheng, Liduan, Tong, Qiangsong
Publicado 2019

Therapeutic targeting of YY1/MZF1 axis by MZF1-uPEP inhibits aerobic glycolysis and neuroblastoma progression

por Fang, Erhu, Wang, Xiaojing, Wang, Jianqun, Hu, Anpei, Song, Huajie, Yang, Feng, Li, Dan, Xiao, Wenjing, Chen, Yajun, Guo, Yanhua, Liu, Yang, Li, Hongjun, Huang, Kai, Zheng, Liduan, Tong, Qiangsong
Publicado 2020

p113 isoform encoded by CUX1 circular RNA drives tumor progression via facilitating ZRF1/BRD4 transactivation

por Yang, Feng, Hu, Anpei, Guo, Yanhua, Wang, Jianqun, Li, Dan, Wang, Xiaojing, Jin, Shikai, Yuan, Boling, Cai, Shuang, Zhou, Yi, Li, Qilan, Chen, Guo, Gao, Haiyang, Zheng, Liduan, Tong, Qiangsong
Publicado 2021

Long-Term Survival of Neuroblastoma Patients Receiving Surgery, Chemotherapy, and Radiotherapy: A Propensity Score Matching Study

por Li, Qilan, Wang, Jianqun, Cheng, Yang, Hu, Anpei, Li, Dan, Wang, Xiaojing, Guo, Yanhua, Zhou, Yi, Chen, Guo, Bao, Banghe, Gao, Haiyang, Song, Jiyu, Du, Xinyi, Zheng, Liduan, Tong, Qiangsong
Publicado 2023